![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 13021 |
FusionGeneSummary for FBLN1_SMC1B |
![]() |
Fusion gene information | Fusion gene name: FBLN1_SMC1B | Fusion gene ID: 13021 | Hgene | Tgene | Gene symbol | FBLN1 | SMC1B | Gene ID | 2192 | 27127 |
Gene name | fibulin 1 | structural maintenance of chromosomes 1B | |
Synonyms | FBLN|FIBL1 | SMC1BETA|SMC1L2 | |
Cytomap | 22q13.31 | 22q13.31 | |
Type of gene | protein-coding | protein-coding | |
Description | fibulin-1 | structural maintenance of chromosomes protein 1BSMC protein 1BSMC1 (structural maintenance of chromosomes 1, yeast)-like 1SMC1 structural maintenance of chromosomes 1-like 2mitosis-specific chromosome segregation protein like protein beta | |
Modification date | 20180522 | 20180519 | |
UniProtAcc | P23142 | Q8NDV3 | |
Ensembl transtripts involved in fusion gene | ENST00000348697, ENST00000402984, ENST00000262722, ENST00000327858, ENST00000442170, ENST00000340923, ENST00000476366, | ENST00000357450, ENST00000404354, | |
Fusion gene scores | * DoF score | 8 X 9 X 5=360 | 4 X 3 X 4=48 |
# samples | 10 | 4 | |
** MAII score | log2(10/360*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FBLN1 [Title/Abstract] AND SMC1B [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FBLN1 | GO:0001933 | negative regulation of protein phosphorylation | 11792823 |
Hgene | FBLN1 | GO:0007162 | negative regulation of cell adhesion | 11792823 |
Hgene | FBLN1 | GO:0007229 | integrin-mediated signaling pathway | 11792823 |
Hgene | FBLN1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 11792823 |
Hgene | FBLN1 | GO:0072378 | blood coagulation, fibrin clot formation | 7642629 |
Hgene | FBLN1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading | 11792823 |
Hgene | FBLN1 | GO:2000146 | negative regulation of cell motility | 11792823 |
Hgene | FBLN1 | GO:2000647 | negative regulation of stem cell proliferation | 11238726 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BLCA | TCGA-DK-A6B2-01A | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000348697 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000348697 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000402984 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000402984 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000262722 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000262722 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000327858 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000327858 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000442170 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000442170 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000340923 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
In-frame | ENST00000340923 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
intron-3CDS | ENST00000476366 | ENST00000357450 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
intron-3CDS | ENST00000476366 | ENST00000404354 | FBLN1 | chr22 | 45898944 | + | SMC1B | chr22 | 45804779 | - |
Top |
FusionProtFeatures for FBLN1_SMC1B |
![]() |
Hgene | Tgene |
FBLN1 | SMC1B |
Meiosis-specific component of cohesin complex. Requiredfor the maintenance of meiotic cohesion, but not, or only to aminor extent, for its establishment. Contributes to axial element(AE) formation and the organization of chromatin loops along theAE. Plays a key role in synapsis, recombination and chromosomemovements. The cohesin complex is required for the cohesion ofsister chromatids after DNA replication. The cohesin complexapparently forms a large proteinaceous ring within which sisterchromatids can be trapped. At anaphase, the complex is cleaved anddissociates from chromatin, allowing sister chromatids tosegregate. The meiosis-specific cohesin complex probably replacesmitosis specific cohesin complex when it dissociates fromchromatin during prophase I (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 1022_1049 | 36 | 1236 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 156_490 | 36 | 1236 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 666_934 | 36 | 1236 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 970_994 | 36 | 1236 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 1022_1049 | 36 | 1162 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 156_490 | 36 | 1162 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 666_934 | 36 | 1162 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 970_994 | 36 | 1162 | Coiled coil | Ontology_term=ECO:0000255 |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 1124_1159 | 36 | 1236 | Compositional bias | Note=Ala/Asp-rich (DA-box) |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 1124_1159 | 36 | 1162 | Compositional bias | Note=Ala/Asp-rich (DA-box) |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 491_665 | 36 | 1236 | Region | Note=Flexible hinge |
Tgene | >SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 491_665 | 36 | 1162 | Region | Note=Flexible hinge |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 112_144 | 26 | 684 | Domain | Anaphylatoxin-like 3 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 176_215 | 26 | 684 | Domain | EGF-like 1 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 216_261 | 26 | 684 | Domain | EGF-like 2%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 262_307 | 26 | 684 | Domain | EGF-like 3%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 308_355 | 26 | 684 | Domain | EGF-like 4%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 356_398 | 26 | 684 | Domain | EGF-like 5%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 36_76 | 26 | 684 | Domain | Anaphylatoxin-like 1 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 399_440 | 26 | 684 | Domain | EGF-like 6%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 441_480 | 26 | 684 | Domain | EGF-like 7%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 481_524 | 26 | 684 | Domain | EGF-like 8%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 525_578 | 26 | 684 | Domain | EGF-like 9%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 77_111 | 26 | 684 | Domain | Anaphylatoxin-like 2 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 112_144 | 26 | 704 | Domain | Anaphylatoxin-like 3 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 176_215 | 26 | 704 | Domain | EGF-like 1 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 216_261 | 26 | 704 | Domain | EGF-like 2%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 262_307 | 26 | 704 | Domain | EGF-like 3%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 308_355 | 26 | 704 | Domain | EGF-like 4%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 356_398 | 26 | 704 | Domain | EGF-like 5%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 36_76 | 26 | 704 | Domain | Anaphylatoxin-like 1 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 399_440 | 26 | 704 | Domain | EGF-like 6%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 441_480 | 26 | 704 | Domain | EGF-like 7%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 481_524 | 26 | 704 | Domain | EGF-like 8%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 525_578 | 26 | 704 | Domain | EGF-like 9%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 77_111 | 26 | 704 | Domain | Anaphylatoxin-like 2 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 112_144 | 26 | 567 | Domain | Anaphylatoxin-like 3 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 176_215 | 26 | 567 | Domain | EGF-like 1 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 216_261 | 26 | 567 | Domain | EGF-like 2%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 262_307 | 26 | 567 | Domain | EGF-like 3%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 308_355 | 26 | 567 | Domain | EGF-like 4%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 356_398 | 26 | 567 | Domain | EGF-like 5%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 36_76 | 26 | 567 | Domain | Anaphylatoxin-like 1 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 399_440 | 26 | 567 | Domain | EGF-like 6%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 441_480 | 26 | 567 | Domain | EGF-like 7%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 481_524 | 26 | 567 | Domain | EGF-like 8%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 525_578 | 26 | 567 | Domain | EGF-like 9%3B calcium-binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 77_111 | 26 | 567 | Domain | Anaphylatoxin-like 2 |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000262722 | + | 1 | 15 | 356_440 | 26 | 684 | Region | Note=Self-association and FN1-binding%3B calcium is necessary for homotypic binding%2C but not for heterotypic binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000327858 | + | 1 | 17 | 356_440 | 26 | 704 | Region | Note=Self-association and FN1-binding%3B calcium is necessary for homotypic binding%2C but not for heterotypic binding |
Hgene | >FBLN1 | chr22:45898944 | chr22:45804779 | ENST00000340923 | + | 1 | 15 | 356_440 | 26 | 567 | Region | Note=Self-association and FN1-binding%3B calcium is necessary for homotypic binding%2C but not for heterotypic binding |
Tgene | SMC1B | chr22:45898944 | chr22:45804779 | ENST00000357450 | - | 0 | 25 | 32_39 | 36 | 1236 | Nucleotide binding | ATP |
Tgene | SMC1B | chr22:45898944 | chr22:45804779 | ENST00000404354 | - | 0 | 23 | 32_39 | 36 | 1162 | Nucleotide binding | ATP |
Top |
FusionGeneSequence for FBLN1_SMC1B |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FBLN1_SMC1B |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
FBLN1 | MPG, APP, NID1, ELN, FBLN1, FGB, FN1, NOV, CTGF, CACNA1A, ATN1, GFI1B, SKIL, SMAD4, TCF7L2, ADAMTSL4, TAF9, SMAD3, NOTCH3, PLSCR1, TDGF1, LTBP4, TANK, YWHAQ, NEDD1, APOA1, BHLHE40, ADAMTSL2, EDC4, DKK1, LGALS9, FCN1, PLSCR4, SFRP4, KCTD9, PTPRK, PSG1, PSG3, WNT4, ZFP41, IFI30, NLGN3, DDIAS, OCLN, DEFA1, COLQ, WNT7A, IRF9, PAK7, EFEMP1, ZNF517, NELL1, FAM19A3, PLA2G10, CCDC89, TYW3, AGRP, TRIM25, MCPH1 | SMC1B | CDCA5, RAD21, STAG1, STAG2, SMC3, REC8 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FBLN1_SMC1B |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FBLN1_SMC1B |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FBLN1 | C0014175 | Endometriosis | 1 | CTD_human |
Hgene | FBLN1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | SMC1B | C0005695 | Bladder Neoplasm | 1 | CTD_human |